Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Business
White House mulls 10% stake in Intel after CEO meeting
The White House may be ready to take a 10% stake in Intel, fueling ongoing speculation an investment is being hammered out, according to Bloomberg. The move would shore up…
Soho House buyout is the end of the party for its members
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.Soho House has long styled itself as a desirable hang-out…
Labubu dolls become 2025's hottest toy craze among kids and adult collectors
The hottest toy of 2025 isn’t just for kids Labubus, the quirky monster plush dolls made by Pop Mart, have exploded into a global phenomenon, doubling as collectibles and…
Apollo’s insurer points finger at rivals over potential conflicts
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.Apollo has hit back against criticism of the close ties…
Trump admin launches comprehensive federal review targeting state laws that hurt national economy
The Trump administration on Friday announced that it will review state laws that have a negative impact on the broader U.S. economy and interstate commerce to address those…
Tennessee Valley Authority agrees to buy nuclear power for Google data centres
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.Google, Kairos Power and the Tennessee Valley Authority…
Powerball jackpot soars to highest of 2025
The Powerball jackpot surged to its biggest amount of the year, reaching an estimated $605 million ahead of Monday night's drawing. The pot grew after nobody won all six…
Client Challenge
Client Challenge
JavaScript is disabled in your browser.
Please enable JavaScript to…
Novo Nordisk to sell weight-loss drug for $499 to eligible customers
Novo Nordisk said on Monday it is offering its diabetes drug Ozempic for $499 per month to eligible cash-paying type 2 diabetes patients in the U.S. The company said in March…
Client Challenge
Client Challenge
JavaScript is disabled in your browser.
Please enable JavaScript to…